ホーム › トリプルネガティブ乳がん › フロリダ州
フロリダ州におけるトリプルネガティブ乳がんの臨床試験
フロリダ州内の拠点で、トリプルネガティブ乳がんに関する47件の研究が参加者を募集しています。
フロリダ州内の都市
- Tampa15件の研究
- Orlando12件の研究
- Miami11件の研究
- Jacksonville9件の研究
- Sarasota8件の研究
- St. Petersburg4件の研究
- Plantation3件の研究
- West Palm Beach3件の研究
公式研究テキスト（英語）
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Advent Health, Orlando
- Florida Cancer Specialists South, Port Charlotte
被験者募集中第1/2相
12歳以上 · 全性別 · 2026/10/02更新 · NCT04585750A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- AdventHealth Cancer Institute, Orlando
被験者募集中第1相
19歳以上 · 全性別 · 2026/10/01更新 · NCT06586957First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
- Florida Cancer Specialists, Sarasota
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06799065Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05867251Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Baptist MD Anderson Cancer Center, Jacksonville
被験者募集中
30歳以上 · 女性 · 2026/09/25更新 · NCT02945579A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
- Florida Cancer Specialists - South ( Site 7004), Fort Myers
- Bioresearch Partner ( Site 0072), Hialeah
- 他2件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06966700Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- Mayo Clinic Jacksonville, Jacksonville
- Moffitt Cancer Center, Tampa
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/25更新 · NCT04981119Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
- AdventHealth Altamonte Springs ( Site 0125), Altamonte Springs
- Orlando Health Cancer Institute ( Site 0030), Orlando
- Comprehensive Hematology Oncology ( Site 0091), St. Petersburg
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06393374A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0007), Altamonte Springs
- Orlando Health Cancer Institute ( Site 0012), Orlando
- Florida Cancer Specialists - East ( Site 7000), West Palm Beach
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06841354Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
- Morton Plant Hospital - Baycare Health System, Clearwater
- Moffitt Cancer Center, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05528133A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/23更新 · NCT06618287Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
- Sylvester Comprehensive Cancer Center, Miami
- Sara Cannon Research Institute Lake Nona, Orlando
- Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05983432A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
- Biogenix Molecular, LLC, Miami
- Advent Health Medical Group Radiation Oncology at Central Florida, Orlando
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/17更新 · NCT07020117Study of Screening Brain MRIs in Stage IV Breast Cancer
- Morton Plant Mease- Baycare, Clearwater
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/15更新 · NCT05115474First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
- University of Miami, Miami
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06657222Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
- Mayo Clinic Florida, Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- Jupiter Medical Center, Jupiter
- 他4件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05633654Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer
- UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
- UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
- UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
- 他7件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT03606967A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer
- BAPTIST ALLIANCE - MCI (Data Collection Only), Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT05570253Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies
- Cleveland Clinic Florida, Weston
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/09/03更新 · NCT07211178A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- SCRI Florida Cancer Specialists - Sarasota, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07029399Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Mayo Clinic in Florida, Jacksonville
被験者募集中第1/2相
16歳以上 · 全性別 · 2026/08/20更新 · NCT05269381SMP-3124LP in Adults With Advanced Solid Tumors
- Advent Health, Celebration
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/12更新 · NCT06526819A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
- Local Institution - 0296, Pembroke Pines
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/08/10更新 · NCT06926868DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs
- Miami Baptist Cancer Institute/, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/08/06更新 · NCT06176261Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- USOR Florida Cancer Specialists South, Fort Myers
- USOR Florida Cancer Specialists North, St. Petersburg
- USOR Florida Cancer Specialists East, West Palm Beach
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/04更新 · NCT05579366Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
- Mayo Clinic Jacksonville, Jacksonville
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/07/29更新 · NCT06562192A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
- Florida Cancer Specialists - Lake Nona, Orlando
- Florida Cancer Specialists - Sarasota, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/28更新 · NCT06150664A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
- Mayo Clinic - Jacksonville, Jacksonville
- Florida Cancer Specialists, Sarasota
- Moffitt Cancer Center, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/29更新 · NCT05377996A Study of LY4175408 in Participants With Advanced Cancer
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute, Orlando
- Florida Cancer Specialists - Sarasota, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/23更新 · NCT07046923Study of XB010 in Subjects With Solid Tumors
- Sarah Cannon Research Institute at Florida Cancer Specialists, Orlando
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/22更新 · NCT06545331A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Florida Cancer Specialists, Sarasota
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/18更新 · NCT07503808BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
- University of Miami Health System, Coral Gables
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/15更新 · NCT05768932MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/11更新 · NCT05076760A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
- Moffitt Cancer Center and Research Institute, Tampa
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04300556Phase 1 Study of CLR 125 in Triple Negative Breast Cancer
- Mayo Clinic Florida, Jacksonville
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/03更新 · NCT07311993I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
- Moffitt Cancer Center, Tampa
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT01042379Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Miami Cancer Institute at Baptist Health (Kendall), Miami
- Miami Cancer Institute at Baptist Health, Plantation
被験者募集中第2相
18歳以上 · 全性別 · 2026/04/29更新 · NCT04468061Personalized Dendritic Cell Vaccine Pilot for High Risk TNBC After Neoadjuvant Therapy
- Moffitt Cancer Center, Tampa
被験者募集中早期第1相
18歳以上 · 全性別 · 2026/04/01更新 · NCT06435351Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
- Baptist Alliance - McI, Miami
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/27更新 · NCT03808337DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
- Moffitt Cancer Center, Tampa
被験者募集中第1相
18歳以上 · 全性別 · 2026/02/05更新 · NCT05504707ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。